Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit in Adults 40 to 65: Study

By Katabella Roberts August 26, 2022 A new study has found that Pfizer’s COVID-19 oral antiviral pill Paxlovid appears to provide little or no benefit for younger adults. Researchers in the Israel-based study, which was published in the New England Journal of Medicine on Wednesday, examined over 109,000 patients between Jan. 9 and March 31 of this year. During the study

Fauci Gets COVID Again After Taking Pfizer’s Treatment — the Drug That Cost Taxpayers $10.5 Billion

06/29/22 Dr. Anthony Fauci said Tuesday he is experiencing a rebound of COVID-19 symptoms after taking Paxlovid, Pfizer’s COVID-19 antiviral pill. Taxpayers are on the hook for $10.5 billion worth of the experimental treatment, under a deal the White House cut with Pfizer. By  Suzanne Burdick, Ph.D. Miss a day, miss a lot. Subscribe to The